SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* ESPOSITO JOSEPH A (Last) (First) (Middle) 4995 GULF OF MEXICO DRIVE, UNIT 501 (Street) LONG BOAT KEY FL 34228 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol MedClean Technologies, Inc. [ MCLN ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 08/06/2010
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								25,538,500	D(3)
Common Stock								20,900,000	I	By E4 LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant	$0.0075	08/06/2010		X			5,538,500	08/04/2008	08/04/2013	Common Stock	5,538,500	$0	0	D(3)
Warrant	$0.004	08/25/2010		X			12,000,000	08/04/2008	08/04/2013	Common Stock	12,000,000	$0	0	I	By E4 LLC
Warrant	(1)							(1)	(1)	Common Stock	(1)		620,000(2)	I	By E4 LLC
Warrant	(1)							(1)	(1)	Common Stock	(1)		112,000,000(2)	I	By E4 LLC

Explanation of Responses:

1. N/A

2. Mr. Esposito currently indirectly beneficially owns 112,620,000 shares issuable upon exercise of warrants and options held by E4, LLC, of which (i) 620,000 warrants are exercisable at a price of $0.0075 per share and (ii) 112,000,000 options are exercisable at a price of $0.004 per share.

3. By Joseph Esposito IRA

Remarks:

This Form 4 is being filed pursuant to (i) the assignment of certain derivative securities from Joseph Esposito, individually, to an entity controlled by Mr. Esposito, E4 LLC, and (ii) certain exercises of warrants, as noted above. Mr. Esposito has not sold any securities underlying the above referenced transactions.

	/s/Joseph A. Esposito	08/31/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.